4 free views remaining today
non-alcoholic fatty liver
ICD-10 Codes
Related ICD-10:
Description
Non-Alcoholic Fatty Liver Disease (NAFLD) Definition and Characteristics
Non-alcoholic fatty liver disease (NAFLD) is a condition where excess fat builds up in the liver cells, not caused by alcohol consumption. This buildup of fat can lead to inflammation and scarring in the liver, which can progress to more severe forms of liver damage.
Key Features of NAFLD:
- Excess fat accumulation in liver cells (steatosis)
- No history of heavy drinking or alcohol-related liver disease
- Often related to being overweight or obese
- Can cause no symptoms or problems for many people
- May progress to more severe forms, such as non-alcoholic steatohepatitis (NASH) and cirrhosis
Prevalence and Risk Factors:
- NAFLD is one of the most common liver diseases worldwide, affecting approximately 30% of the global population.
- Risk factors include:
- Being overweight or obese
- High blood sugar (diabetes)
- High cholesterol
- High blood pressure
- Family history of NAFLD
Symptoms and Diagnosis:
- Many people with NAFLD do not experience symptoms, but some may have:
- Fatigue
- Weight loss
- Abdominal pain or discomfort
- Diagnosis is typically made through imaging tests (e.g., ultrasound, CT scan) and liver biopsy.
References:
- [1] Nonalcoholic fatty liver disease. Compared with a healthy liver (top), a fatty liver (bottom) appears bigger and discolored.
- [2] Key points about metabolic dysfunction-associated steatotic liver disease.
- [3] Non-Alcoholic Fatty Liver Disease Definition.
- [4] Oct 24, 2024 — Nonalcoholic Fatty Liver Disease is the build-up of extra fat in liver cells not caused by alcohol.
- [5] NAFLD (also referred to as metabolic dysfunction-associated steatotic liver disease, or MASLD), is a condition in which excess fat builds up in your liver.
Additional Characteristics
- Weight loss
- Fatigue
- Abdominal pain or discomfort
- High blood pressure
- Excess fat accumulation in liver cells (steatosis)
- No history of heavy drinking or alcohol-related liver disease
- Often related to being overweight or obese
- Can cause no symptoms or problems for many people
- May progress to more severe forms, such as non-alcoholic steatohepatitis (NASH) and cirrhosis
- Being overweight or obese
- High blood sugar (diabetes)
- High cholesterol
- Family history of NAFLD
Signs and Symptoms
Non-alcoholic fatty liver disease (NAFLD) can manifest in various ways, and its symptoms may be similar to those of other conditions. Here are some common signs and symptoms associated with NAFLD:
- Abdominal pain: A dull or aching pain in the top right of the tummy (over the lower right side of the ribs) is often reported by individuals with NAFLD [1][3].
- Fatigue: Extreme tiredness, also known as fatigue, is another common symptom of NAFLD [2][7].
- Weight loss: Unexplained weight loss or loss of appetite can be indicative of NAFLD [4][5].
- Yellowish skin and whites of the eyes (jaundice): In some cases, individuals with NAFLD may experience yellowing of the skin or eyes due to liver dysfunction [2][6].
- Itchy skin: Itching or itchy skin can be a symptom of NAFLD, although this is not as common as other symptoms [1].
- Abdominal swelling (ascites): Fluid accumulation in the abdomen can occur in advanced cases of NAFLD [1].
It's essential to note that some individuals with NAFLD may not experience any noticeable symptoms at all. If you're concerned about your liver health or are experiencing any of these symptoms, consult a healthcare professional for proper evaluation and diagnosis.
References: [1] Context result 1: Apr 4, 2024 — The liver · Itchy skin. · Abdominal swelling, also called ascites (uh-SY-teez). · Shortness of breath. · Swelling of the legs. · Spider-like ... [2] Context result 2: Severe tiredness (fatigue) · Pain in the right upper belly (abdomen) · Weakness · Weight loss · Yellowing of the skin or eyes (jaundice) · Spiderlike blood vessels ... [3] Context result 4: Symptoms of non-alcoholic fatty liver disease (NAFLD) · a dull or aching pain in the top right of the tummy (over the lower right side of the ribs) · extreme ... [4] Context result 5: What are the signs and symptoms of steatotic (fatty) liver disease? · Nausea. · Loss of appetite. · Unexplained weight loss. · Yellowish skin and whites of the eyes ... [5] Context result 6: Bleeding easily; Bruising easily; Itchy skin; Yellow discoloration in the skin and eyes (jaundice); Fluid accumulation in your abdomen; Loss of appetite; Nausea ... [7] Context result 7: May 29, 2023 — Symptoms of NAFLD · a dull or aching pain in the top right of the tummy (over the lower right side of the ribs) · fatigue (extreme tiredness) ...
Additional Symptoms
- Itchy skin
- Yellowish skin and whites of the eyes (jaundice)
- Abdominal swelling (ascites)
- weight loss
- abdominal pain
- fatigue
Diagnostic Tests
Non-alcoholic fatty liver disease (NAFLD) can be diagnosed through a combination of physical examination, medical history, and various diagnostic tests.
Physical Exam: A doctor will typically perform a physical exam to check for signs of NAFLD, such as an enlarged liver or signs of metabolic syndrome. They may also calculate your body mass index (BMI) to assess your weight status [2].
Medical History: Your healthcare provider will ask about your medical history, including any previous liver problems, diabetes, high blood pressure, or other conditions that may be related to NAFLD.
Diagnostic Tests: The following tests can help diagnose and rule out other liver diseases:
- Imaging Tests: Ultrasound, CT scan, or MRI may show fat deposits in the liver [4]. These tests are often used as a first-line imaging test for patients with suspected NAFLD.
- Blood Tests: Blood tests can measure levels of liver enzymes, such as alanine transaminase (ALT), which can indicate liver damage. However, ALT levels are not a reliable predictor of NAFLD [5].
- Liver Biopsy: A liver biopsy is considered the gold standard for diagnosing NAFLD and assessing its severity. It involves taking a small sample of liver tissue for examination under a microscope.
Other Tests: Your healthcare provider may also use other tests to rule out other conditions, such as:
- Alcohol Use Assessment: To determine whether the fat in your liver is due to alcoholic fatty liver disease or non-alcoholic fatty liver disease [3].
- Metabolic Panel: To assess your metabolic health and identify any underlying conditions that may be contributing to NAFLD.
It's essential to note that a diagnosis of NAFLD can only be made by a healthcare professional, based on a combination of these tests and a thorough medical evaluation.
Additional Diagnostic Tests
- Blood Tests
- Ultrasound
- Liver Biopsy
- MRI
- CT scan
- Alcohol Use Assessment
- Metabolic Panel
Treatment
Treatment Options for Non-Alcoholic Fatty Liver Disease (NAFLD)
Non-alcoholic fatty liver disease (NAFLD) is a condition where excess fat accumulates in the liver cells, not caused by alcohol consumption. While there are no specific medications approved for NAFLD, various treatments can help manage the condition and prevent its progression to more severe forms like nonalcoholic steatohepatitis (NASH).
Lifestyle Changes
- Weight Loss: Losing weight through a combination of diet and exercise is often recommended as the primary treatment for NAFLD. This approach helps reduce liver fat and improve insulin sensitivity.
- Healthy Diet: Eating a balanced diet rich in fruits, vegetables, whole grains, and lean proteins can help manage NAFLD.
Medications
While there are no specific medications approved for NAFLD, certain drugs have shown promise in treating the condition:
- Insulin Sensitizers: Drugs like pioglitazone have been studied as potential treatments for NAFLD. These medications improve insulin sensitivity and can help reduce liver fat.
- Lipid-Lowering Drugs: Statins, such as simvastatin, may be prescribed to lower cholesterol levels and reduce liver inflammation.
- Resmetirom (Rezdiffra): This medication has been approved by the FDA for the treatment of adults with noncirrhotic NASH. It is used in combination with diet and exercise.
Other Treatment Options
- Weight Loss Surgery: In some cases, weight loss surgery may be recommended for individuals who have a significant amount to lose.
- Combination Therapy: A pilot study has explored the use of ezetimibe and acarbose as a combination therapy for NAFLD. Further research is needed to confirm its efficacy.
Important Considerations
It's essential to note that while these treatments can help manage NAFLD, they may not be suitable for everyone. Consult with a healthcare professional to determine the best course of treatment based on individual circumstances.
Sources:
- [1] March 24, 2024 - "Treatment Options for Non-Alcoholic Fatty Liver Disease (NAFLD)"
- [2] November 1, 2023 - "Weight Loss Surgery: An Option for NAFLD"
- [3] September 25, 2024 - "Treatments for NAFLD and NASH"
Recommended Medications
- Resmetirom (Rezdiffra)
- ezetimibe
- pioglitazone
- simvastatin
- Simvastatin
- acarbose
- Acarbose
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Non-alcoholic fatty liver disease (NAFLD) can be challenging to diagnose due to its similarity in presentation with other liver conditions. Here are some key points to consider for differential diagnosis:
- Obesity, type II diabetes, dyslipidemia, and insulin resistance are the well-known primary causes of NAFLD [4]. However, other less common conditions can also cause a similar presentation.
- Hepatitis C virus, autoimmune liver disease, iron-overload diseases, and Wilson disease should be considered in the differential diagnosis of fatty liver disease [3].
- A definitive diagnosis of NAFLD depends on three factors: evidence of fatty infiltration from either imaging (ultrasound, CT, or MRI) or histology, absence of other causes of liver disease or steatosis, and exclusion of secondary causes such as viral hepatitis, autoimmune liver disease, or metabolic disorders [8].
- Liver biopsy is considered the gold standard for diagnosing NAFLD, but it may not be routinely recommended in all cases. Non-invasive tools like fibrosis scoring can also be used to assess the severity of NAFLD [9].
In terms of distinguishing NAFLD from other liver conditions, here are some key points:
- Alcoholic fatty liver disease is typically associated with a history of excessive alcohol consumption and may not require liver biopsy for diagnosis.
- Hepatitis C virus infection can also cause liver steatosis, but it should be distinguished from NAFLD based on serological tests and histopathology.
- Autoimmune liver disease, such as autoimmune hepatitis, can present with similar symptoms to NAFLD, but it requires specific serological markers and histopathological findings for diagnosis.
Overall, a comprehensive diagnostic approach is essential to accurately diagnose and differentiate NAFLD from other liver conditions.
Additional Differential Diagnoses
- lysosomal acid lipase deficiency
- metabolic dysfunction-associated steatohepatitis
- hemochromatosis type 2A
- hemochromatosis type 3
- hemochromatosis type 2
- Wolman disease
- hepatitis B
- Insulin resistance
- Dyslipidemia
- Type II diabetes
- Hepatitis C virus
- Autoimmune liver disease
- Iron-overload diseases
- Alcoholic fatty liver disease
- Hepatitis B virus infection (mentioned in the context of distinguishing from NAFLD)
- Autoimmune liver disease (such as autoimmune hepatitis)
- obesity
- Wilson disease
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_3417
- owl#annotatedSource
- t353816
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0080546
- core#notation
- DOID:0080546
- IAO_0000115
- A metabolic dysfunction-associated steatotic liver disease characterized by the absence of inflammation and hepatocyte injury in the form of hepatocyte ballooning.
- oboInOwl#hasExactSynonym
- nonalcoholic fatty liver
- rdf-schema#label
- non-alcoholic fatty liver
- rdf-schema#comment
- NAFL was not addressed in the 2023 international update that revised the nomenclature and definition of NAFLD/MASLD and NASH/MASH. Generally considered a subtype of NAFLD, it is unclear if NAFL should continue to be considered a distinct disease in clinical practice. Use care when annotating data to this disease. It may be deprecated and merged into MASLD in the future (2023-11-29, JAB).
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_0080208
- relatedICD
- http://example.org/icd10/K70.0
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.